Drug comparisons
Tirzepatide vs Insulin Icodec
Compare Tirzepatide (Mounjaro) vs weekly Insulin Icodec (Awiqli) for T2D: dual GIP/GLP-1 vs basal insulin. A1C, weight loss, GI effects vs hypo risk.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for type 2 diabetes patients failing oral therapies who need injectable treatment balancing glycemic control, weight, and injection frequency.
Bottom line
Tirzepatide may be preferable for patients with obesity due to weight loss, while insulin icodec suits those requiring basal insulin support with weekly convenience.
All medication comparisons